In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.
Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Effects of Mixed Dusts on Pulmonary Inflammation, Airway Reactivity and Susceptibility to Pulmonary Infection, RFA# OH-00-009.
Times and Date: 8 a.m.-8:30 a.m., July 26, 2000 (Open); 8:30 a.m.-5 p.m., July 26, 2000 (Closed).
Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314.
Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Associate Director for Management and Operations, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to RFA-OH-00-009.
Contact Person for More Information: Michael J. Galvin, Jr., Ph.D., Health Science Administrator, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 1600 Clifton Road, NE., m/s D30 Atlanta, Georgia 30333. Telephone 404/639-3525, e-mail firstname.lastname@example.org.
The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: May 30, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention CDC.
[FR Doc. 00-13941 Filed 6-2-00; 8:45 am]
BILLING CODE 4163-19-P